Nektar TherapeuticsNKTRNASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
23.45%
↓ 73% below average
Average (9y)
88.29%
Historical baseline
Range
High:1253.44%
Low:-284.24%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 23.45% |
| 2023 | 42.80% |
| 2022 | 46.15% |
| 2021 | -17.42% |
| 2020 | 13.66% |
| 2019 | -163.96% |
| 2018 | 1253.44% |
| 2017 | 47.15% |
| 2016 | -284.24% |
| 2015 | -78.17% |